The risk of coronary heart disease in men with erectile dysfunction

European Urology

Volumn 44, Issue 3, 2003, Pages 366-371

  Speel, T G W ^a   Van Langen, H ^a   Meuleman, E J H ^a   Cormio, Luigi ^b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

Coronary heart disease; Duplex ultrasonography; Erectile dysfunction; Prevention

Indexed keywords

ADULT; AGED; AGING; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORRELATION ANALYSIS; ECHOGRAPHY; EPIDEMIOLOGICAL DATA; ERECTILE DYSFUNCTION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; NETHERLANDS; PENILE BLOOD VESSEL; PRIORITY JOURNAL; PROPHYLAXIS;

EID: 0041857960     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0302-2838(03)00304-X     Document Type: Article

References (37)

1. E.J Meuleman L.H Donkers C Robertson M Keech P Boyle L.A Kiemeney Erectile dysfunction: prevalence and effect on the quality of life Boxmeer study Ned. Tijdschr. Geneeskd 24 145 2001 576 581
2. H.A Feldman C.B Johannes C.A Derby K.P Kleinman B.A Mohr A.B Araujo Erectile dysfunction and coronary risk factors: prospective results from the Massachusetts Male Aging Study Prev. Med. 30 2000 328 338
3. C.B Johannes A.B Araujo H.A Feldman C.A Derby K.P Kleinman J.B McKinlay Incidence of erectile dysfunction in men 40 to 69 years old: longitudinal results from the Massachusetts Male Aging Study J. Urol. 163 2000 460 463
4. G Jackson Erectile dysfunction and cardiovascular disease Int. J. Clin. Pract. 53 1999 363 368
5. M Kirby G Jackson J Betteridge K Friedli Is erectile dysfunction a marker for cardiovascular disease? Int. J. Clin. Pract. 55 2001 614 618
6. A Vermeulen L Verdonck J.M Kaufman A critical evaluation of simple methods for the estimation of free testosterone in serum J. Clin. Endocrinol. Metab. 84 1999 3666 3672
7. E.J Meuleman B.L Bemelmans W.H Doesburg W.N van Asten S.H Skotnicki F.M Debruyne Penile pharmaco duplex ultrasonography: a dose-effect study comparing papaverine, papaverine/phentolamine and prostaglandine E1 J. Urol. 148 1992 63 66
8. T.G Speel H van Langen H Wijkstra E.J Meuleman Penile duplex pharmaco-ultrasonography revisited: revalidation of the parameters of the cavernous arterial response J. Urol. 169 2003 216 220
9. K.M Anderson P.W.F Wilson P.M Odell W.B Kannel An updated coronary risk profile. A statement for health professionals Circulation 83 1991 356 362
10. A Bortolli F Parazinni E Colli M Landoni The epidemiology of erectile dysfunction and its risk factors Int. J. Androl. 20 1997 323 334
11. A Greenstein J Chen H Miller H Matzkin Y Villa Z Braf Does severity of ischemic coronary disease correlate with erectile function? Int. J. Impot. Res. 9 1997 123 126
12. M.R Pritzker The penile stress test: A window to the hearts of man? Circulation 100 1999 3751A
13. S.W Kim J Paick D.W Park I Chae B Oh Potential predictors of asymptomatic ischemic heart disease in patients with vasculogenic erectile dysfunction Urology 58 2001 441 445
14. Y Kawanishi K.S Lee K Kimura T Koizumi H Nakatsuji K Kojima Screening of ischemic heart disease with cavernous artery blood flow in erectile dysfunctional patients Int. J. Impot. Res. 13 2001 100 103
15. H Solomon J Man G Jackson The value of routine cardiovascular assessment in patients with erectile dysfunction Circulation 106 2002 II-749A
16. R Virag D Frydman P Bouilly Is impotence an arterial disorder? A study of arterial risk factors in 440 impotent men Lancet 1 1985 181 184
17. R Leriche Des obliterations artérielles hautes comme cause d’une insuffisance circulatoire des members inférieurs Bull. Soc. Chir. 49 1923 1404
18. S Capewell R Beaglehole M Seddon J.J McMurray Explanation for the decline in coronary heart disease rates in Auckland, New Zealand, between 1982 and 1993 Circulation 26 2000 1511 1516
19. M.L Bots D.E Grobbee Decline of coronary heart disease mortality in The Netherlands from 1978 to 1985: contribution of medical care and changes over time in presence of major cardiovascular risk factors J. Cardiovasc. Risk 3 1996 271 276
20. A.J Dobvson H.M Alexander R.F Heller D.M Lloyd How soon after quitting smoking does risk of heart attack decline? J. Clin. Epidemiol. 44 1991 1247 1253
21. P Langeluddecke The role of behavioral change procedures in multifactorial coronary heart disease prevention programs Prog. Behav. Modif. 20 1986 199 225
22. R.R Pate M Pratt S.N Blair W.L Haskell C.A Macera C Bouchard Physical activity and public health. A recommendation from the Center for Disease Control and Prevention and the American College of Sperts Medicine JAMA 273 1995 402 407
23. C.A Derby B.A Mohr I Goldstein H.A Feldman C.B Johannes J.B McKinlay Modifiable risk factors and erectile dysfunction: Can lifestyle changes modify risk? Urology 56 2000 302 306
24. F.M Kramer R.W Jeffery J.L Forster M.K Snell Long-term follow-up of behavioural treatment for obesity: patterns of weight gain among men and women Int. J. Obes. 13 1989 124 136
25. Peto R McMahon J Cuttler R Collins P Sorlie J Neaton R Abbott Blood pressure, stroke and coronar heart disease. Part 1. Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias Lancet 335 1990 765 774
26. R Peto S Yusuf R Collins Cholesterol-lowering trials results in their epidemiological context Circulation 72 Suppl. III 1985 45 53
27. J.E Rossouw B Lewis B.M Rifkind The value of lowering cholesterol after myocardial infarction N Eng. J. Med. 323 1990 1112 1119
28. J Holme An analysis of randomized trials evaluating the effects of cholesterol reduction on total mortality and coronary heart disease incidence Circulation 82 1990 1916 1924
29. T.J Smilde S van Wissen H Wollerheim M.D Trip J.J.P Kastelein A.F.H Stalenhoef Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP): a prospective, randomized, double-blind trial Lancet 357 2001 577 581
30. E Lonn S Yusuf V Dzavik C Doris Q Yi S Smith SECURE Investigators. Effects of ramipril and vitamin E on atherosclerosis: the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE) Circulation 103 2001 919 925
31. R Fogari A Zoppi L Poletti G Marasi A Mugellini L Corradi Sexual activity in hypertensive men treated with valsartan or carvedilol: a crossover study Am. J. Hypertens. 14 2001 27 31
32. J.L Listerri J.V Lozano Vidal J Aznar Vicente M Argaya Roca C Pol Bravo M.A Sanchez Zamorano Sexual dysfunction in hypertensive patients treated with losartan Am. J. Med. Sci. 321 2001 336 341
33. T.M Hale H Okabe T.L Bushfield J.P.W Heaton M.A Adams Recovery of erectile function after brief aggressive antihypertensive therapy J. Urol. 168 2002 348 354
34. Y Kawanishi K.S Lee K Kimura T Koizumi H Nakatsuji K Kojima Screening of ischemic heart disease with cavernous artery blood flow in erectile dysfunctional patients Int. J. Impot. Res. 13 2001 100 103
35. R Fogari A Zoppi L Poletti G Marasi A Mugellini L Corradi Sexual activity in hypertensive men treated with valsartan or carvedilol: a crossover study Am. J. Hypertens 14 2001 27 31
36. J.L Listerri J.V Lozano Vidal J Aznar Vicente M Argaya Roca C Pol Bravo M.A Sanchez Zamorano Sexual dysfunction in hypertensive patients treated with losartan Am. J. Med. Sci. 321 2001 336 341
37. T.M Hale H Okabe T.L Bushfield J.P.W Heaton M.A Adams Recovery of erectile function after brief aggressive antihypertensive therapy J. Urol. 168 2002 348 354